New York State Common Retirement Fund’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,239
Closed -$18.4K 3320
2025
Q1
$18.4K Hold
12,239
﹤0.01% 2994
2024
Q4
$28.9K Hold
12,239
﹤0.01% 2985
2024
Q3
$360K Sell
12,239
-3,400
-22% -$78.3K ﹤0.01% 2068
2024
Q2
$193K Buy
15,639
+1
+0% +$21 ﹤0.01% 2441
2024
Q1
$317K Sell
15,638
-9
-0.1% -$207 ﹤0.01% 2260
2023
Q4
$352K Sell
15,647
-72
-0.5% -$1.52K ﹤0.01% 2232
2023
Q3
$262K Buy
15,719
+118
+0.8% +$2.34K ﹤0.01% 2306
2023
Q2
$383K Sell
15,601
-4,226
-21% -$102K ﹤0.01% 2211
2023
Q1
$478K Sell
19,827
-7,786
-28% -$216K ﹤0.01% 2196
2022
Q4
$816K Buy
27,613
+14
+0.1% +$503 ﹤0.01% 2065
2022
Q3
$1.15M Buy
27,599
+36
+0.1% +$972 ﹤0.01% 1899
2022
Q2
$775K Sell
27,563
-71
-0.3% -$1.79K ﹤0.01% 2154
2022
Q1
$1.03M Sell
27,634
-39
-0.1% -$1.65K ﹤0.01% 2097
2021
Q4
$1.21M Sell
27,673
-25
-0.1% -$1.31K ﹤0.01% 2039
2021
Q3
$1.72M Sell
27,698
-5,340
-16% -$446K ﹤0.01% 1840
2021
Q2
$2.82M Buy
33,038
+3,938
+14% +$211K ﹤0.01% 1656
2021
Q1
$1.31M Buy
29,100
+8,200
+39% +$323K ﹤0.01% 2003
2020
Q4
$143K Hold
20,900
﹤0.01% 2879
2020
Q3
$241K Sell
20,900
-11,700
-36% -$52.7K ﹤0.01% 2559
2020
Q2
$100K Buy
+32,600
New +$148K ﹤0.01% 2948
2015
Q3
Sell
-2,243
Closed -$27K 3188
2015
Q2
$27K Buy
+2,243
New +$30.7K ﹤0.01% 3262

Other funds holding FLNA

New York State Common Retirement Fund's FLNA Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 12,239 shares — an estimated $18.4K sold.

New York State Common Retirement Fund first reported a position in FLNA in Q2 2015 and held it in 21 quarters. The position peaked at $2.82M in Q2 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 12,239 Filana Therapeutics shares in Q2 2025, an estimated $18.4K.
  • New York State Common Retirement Fund first reported a position in Filana Therapeutics in Q2 2015 and held it in 21 quarters.
  • New York State Common Retirement Fund's Filana Therapeutics position peaked at $2.82M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.